A detailed history of Providence Capital Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 53,572 shares of SNY stock, worth $2.62 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
53,572
Previous 54,496 1.7%
Holding current value
$2.62 Million
Previous $2.92 Million 10.95%
% of portfolio
0.59%
Previous 0.79%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$45.75 - $52.48 $42,273 - $48,491
-924 Reduced 1.7%
53,572 $2.6 Million
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $28,124 - $30,470
552 Added 1.02%
54,496 $2.92 Million
Q2 2023

Aug 10, 2023

BUY
$50.45 - $57.18 $64,929 - $73,590
1,287 Added 2.44%
53,944 $2.91 Million
Q1 2023

May 17, 2023

SELL
$45.86 - $54.45 $129 Million - $153 Million
-2,812,937 Reduced 98.16%
52,657 $2.87 Million
Q1 2023

May 17, 2023

BUY
$45.86 - $54.45 $131 Million - $156 Million
2,859,972 Added 50871.08%
2,865,594 $156 Million
Q1 2023

May 10, 2023

SELL
$45.86 - $54.45 $3 Million - $3.57 Million
-65,500 Reduced 92.1%
5,622 $305,000
Q4 2022

Feb 07, 2023

SELL
$38.86 - $48.55 $21,334 - $26,653
-549 Reduced 0.77%
71,122 $3.44 Million
Q3 2022

Nov 09, 2022

BUY
$37.22 - $100.5 $851,965 - $2.3 Million
22,890 Added 46.92%
71,671 $2.73 Million
Q2 2022

Aug 09, 2022

BUY
$48.99 - $57.46 $92,297 - $108,254
1,884 Added 4.02%
48,781 $2.44 Million
Q1 2022

May 12, 2022

BUY
$48.48 - $53.65 $174,673 - $193,300
3,603 Added 8.32%
46,897 $2.41 Million
Q4 2021

Feb 11, 2022

BUY
$47.07 - $52.35 $84,678 - $94,177
1,799 Added 4.34%
43,294 $2.17 Million
Q3 2021

Nov 09, 2021

BUY
$47.89 - $53.12 $183,418 - $203,449
3,830 Added 10.17%
41,495 $2 Million
Q2 2021

Aug 09, 2021

BUY
$49.36 - $54.25 $112,047 - $123,147
2,270 Added 6.41%
37,665 $1.98 Million
Q1 2021

May 13, 2021

BUY
$45.46 - $50.51 $115,422 - $128,244
2,539 Added 7.73%
35,395 $1.75 Million
Q4 2020

Feb 11, 2021

BUY
$45.3 - $51.62 $241,947 - $275,702
5,341 Added 19.41%
32,856 $1.6 Million
Q3 2020

Nov 13, 2020

BUY
$49.47 - $53.77 $44,127 - $47,962
892 Added 3.35%
27,515 $1.38 Million
Q2 2020

Aug 04, 2020

SELL
$42.91 - $52.5 $405,027 - $495,547
-9,439 Reduced 26.17%
26,623 $1.36 Million
Q1 2020

May 12, 2020

BUY
$38.02 - $51.66 $53,189 - $72,272
1,399 Added 4.04%
36,062 $1.58 Million
Q4 2019

Feb 13, 2020

BUY
$44.25 - $50.86 $25,842 - $29,702
584 Added 1.71%
34,663 $1.74 Million
Q3 2019

Nov 13, 2019

BUY
$40.34 - $46.64 $15,934 - $18,422
395 Added 1.17%
34,079 $1.58 Million
Q2 2019

Aug 13, 2019

BUY
$40.43 - $44.3 $50,860 - $55,729
1,258 Added 3.88%
33,684 $1.46 Million
Q1 2019

May 08, 2019

BUY
$40.83 - $45.43 $32,092 - $35,707
786 Added 2.48%
32,426 $1.44 Million
Q4 2018

Feb 01, 2019

BUY
$41.48 - $45.59 $54,836 - $60,269
1,322 Added 4.36%
31,640 $1.37 Million
Q3 2018

Nov 08, 2018

BUY
$40.0 - $44.84 $12,080 - $13,541
302 Added 1.01%
30,318 $1.35 Million
Q2 2018

Aug 08, 2018

BUY
$37.63 - $41.22 $355,979 - $389,941
9,460 Added 46.02%
30,016 $1.2 Million
Q1 2018

May 10, 2018

BUY
$38.98 - $45.76 $81,429 - $95,592
2,089 Added 11.31%
20,556 $824,000
Q4 2017

Feb 12, 2018

BUY
$42.86 - $50.61 $791,495 - $934,614
18,467
18,467 $794,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.